FDA delay on biosimilars Is a safety risk for patients

[HFIAdmin]

Fellow PBSA member Lawrence LaMotte stresses the importance for Congress to use their oversight and ensure the FDA publishes guidance on #biosimilars issues essential to patient safety today in The Hill.

bit.ly/1SvhVfe